Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toon Van Gorp

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
Cancers|April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation StudyRafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trialTine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2024
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trialTine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
tRNA-derived small RNA 3'U-tRF<sup>ValCAC</sup> promotes tumour migration and early progression in ovarian cancerKonstantina Panoutsopoulou, Paraskevi Magkou, Tobias Dreyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2016
Comparison of Intraoperative γ-Probe Imaging and Postoperative SPECT/CT in Detection of Sentinel Nodes Related to the OvaryStéphanie C J M Speth, Roy F P M Kruitwagen, Marjolein Kleppe, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 22, 2019
What do we need to know about anatomy in gynaecology: A Delphi consensus studyDorothea M Koppes, Charlotte P R Triepels, Annelieke N Schepens-Franke, et al.
Gynecologic Oncology|July 13, 2021
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteriaJolien Haesen, Rawand Salihi, Toon Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2026
Pre-operative assessment in International Federation of Gynaecology and Obstetrics-2009 stage IB2 to IIB cervical cancer: role of delayed gadolinium-enhanced magnetic resonance imaging after neoadjuvant chemotherapyVincent Vandecaveye, Marie-Sofie Walgraeve, Frederik De Keyzer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2014
Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subsetArnold-Jan Kruse, Sabrina Croce, Roy F P M Kruitwagen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancerGiorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Cancers|April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation StudyRafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trialTine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2024
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trialTine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
tRNA-derived small RNA 3'U-tRF<sup>ValCAC</sup> promotes tumour migration and early progression in ovarian cancerKonstantina Panoutsopoulou, Paraskevi Magkou, Tobias Dreyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2016
Comparison of Intraoperative γ-Probe Imaging and Postoperative SPECT/CT in Detection of Sentinel Nodes Related to the OvaryStéphanie C J M Speth, Roy F P M Kruitwagen, Marjolein Kleppe, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 22, 2019
What do we need to know about anatomy in gynaecology: A Delphi consensus studyDorothea M Koppes, Charlotte P R Triepels, Annelieke N Schepens-Franke, et al.
Gynecologic Oncology|July 13, 2021
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteriaJolien Haesen, Rawand Salihi, Toon Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2026
Pre-operative assessment in International Federation of Gynaecology and Obstetrics-2009 stage IB2 to IIB cervical cancer: role of delayed gadolinium-enhanced magnetic resonance imaging after neoadjuvant chemotherapyVincent Vandecaveye, Marie-Sofie Walgraeve, Frederik De Keyzer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2014
Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subsetArnold-Jan Kruse, Sabrina Croce, Roy F P M Kruitwagen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancerGiorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
Pageof 17